Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PrevinC
- Development stage
- Phase 4
- Lead developer
- BioHealth Technologies
- Administration
- Intranasal
01
Overview
**PrevinC** is an unapproved homeopathic intranasal solution marketed by BioHealth Technologies for temporary relief of cold and flu symptoms. Its labeled active ingredient is *Citrus limon* Burm. 1X HPUS; the product also contains isopropyl alcohol, sesame oil, and aloe vera oil extract as inactive ingredients. The label claims that the product moisturizes the nasal passages and provides a protective nasal barrier, but states that it has not been evaluated by the FDA for safety or efficacy and that the FDA is not aware of scientific evidence supporting homeopathy as effective. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=6da146ed-61b0-427b-b054-659cdde4adc6))
- Brand names
- PrevinC
Beyond the preview
Go deeper on PrevinC.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PrevinC.